PROFUSA, INC. Increase (Decrease) in Deferred Income Taxes
PROFUSA, INC. (PFSA) reported Increase (Decrease) in Deferred Income Taxes of $13.66 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredIncomeTaxes · last filed 2025-08-14
- PROFUSA, INC. increase (decrease) in deferred income taxes for the quarter ending 2024-12-31 was $0.00.
- PROFUSA, INC. increase (decrease) in deferred income taxes for the quarter ending 2024-09-30 was $0.00.
- PROFUSA, INC. increase (decrease) in deferred income taxes for the quarter ending 2024-06-30 was $0.00.
- PROFUSA, INC. increase (decrease) in deferred income taxes for the quarter ending 2024-03-31 was $13.66K.
- PROFUSA, INC. increase (decrease) in deferred income taxes for fiscal 2024 was $13.66K, a 41.32% decline from fiscal 2023.
- PROFUSA, INC. increase (decrease) in deferred income taxes for fiscal 2023 was $23.28K.
| Period end | Increase (Decrease) in Deferred Income Taxes 3 month | Increase (Decrease) in Deferred Income Taxes 6 month | Increase (Decrease) in Deferred Income Taxes 9 month | Increase (Decrease) in Deferred Income Taxes 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $0.00 derived: sum of 2 quarters · filed 2025-03-31 | $0.00 derived: sum of 3 quarters · filed 2025-08-14 | $13.66K 10-K · filed 2025-03-31 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-12-17 | $0.00 derived: sum of 2 quarters · filed 2025-08-14 | $13.66K 10-Q · filed 2024-12-17 | $0.00 derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $13.66K 10-Q · filed 2025-08-14 | $0.00 derived: sum of 3 quarters · filed 2025-08-14 | $0.00 derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $13.66K 10-Q · filed 2025-06-13 | $0.00 derived: sum of 2 quarters · filed 2025-06-13 | $0.00 derived: sum of 3 quarters · filed 2025-06-13 | |
| 2023-12-31 | -$13.66K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$13.66K derived: sum of 2 quarters · filed 2025-03-31 | $23.28K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-12-17 | $36.94K 10-Q · filed 2024-12-17 | ||
| 2023-06-30 | $36.94K 10-Q · filed 2024-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |